CoChat

Intranasal and inhaled fluticasone propionate for pollen‐induced rhinitis and asthma

Dahl, R., Nielsen, L. P., Kips, J., Foresi, A., van Cauwenberge, P., Tudoric, N., Howarth, P., Richards, D. H., Williams, M., Pauwels, R., the SPIRA Study Group · 2005 · Allergy
Cited by 88

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Studies suggest that nasal treatment might influence lower airway symptoms and function in patients with comorbid rhinitis and asthma. We investigated the effect of intranasal, inhaled corticosteroid or the combination of both in patients with both pollen‐induced rhinitis and asthma. Methods: A total of 262 patients were randomized to 6 weeks’ treatment with intranasal fluticasone propionate (INFP) 200 μ g o.d., inhaled fluticasone propionate (IHFP) 250 μ g b.i.d., their combination, or intranasal or inhaled placebo, in a multicentre, double‐blind, parallel‐group study. Treatment was started 2 weeks prior to the pollen season and patients recorded their nasal and bronchial symptoms twice daily. Before and after 4 and 6 weeks’ treatment, the patients were assessed for lung function, methacholine responsiveness, and induced sputum cell counts. Results: Intranasal fluticasone propionate significantly increased the percentages of patients reporting no nasal blockage, sneezing, or rhinorrhoea during the pollen season, compared with IHFP or intranasal or inhaled placebo. In contrast, only IHFP significantly improved morning peak‐flow, forced expiratory volume in 1 second (FEV 1) and methacholine PD 20, and the seasonal increase in the sputum eosinophils and methacholine responsiveness. Conclusions: In patients with pollen‐induced rhinitis and asthma, the combination of intranasal and IHFP is needed to control the seasonal increase in nasal and asthmatic symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1398-9995.2005.00819.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 88

Metadata

Authors
Dahl, R., Nielsen, L. P., Kips, J., Foresi, A., van Cauwenberge, P., Tudoric, N., Howarth, P., Richards, D. H., Williams, M., Pauwels, R., & the SPIRA Study Group
Venue
Allergy
Publisher
Wiley
Published
2005-06-02
Volume
60
Issue
7
Pages
875-881
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W1966642551
Cited by
88
References
5
FWCI
4.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intranasal and inhaled fluticasone propionate for pollen‐induced rhinitis and asthma. https://app.cochat.ai/papers/10.1111/j.1398-9995.2005.00819.x
The paper
Dahl, R., Nielsen, L. P., Kips, J., Foresi, A., van Cauwenberge, P., Tudoric, N., Howarth, P., Richards, D. H., Williams, M., Pauwels, R., & the SPIRA Study Group. (2005). Intranasal and inhaled fluticasone propionate for pollen‐induced rhinitis and asthma. Allergy. https://doi.org/10.1111/j.1398-9995.2005.00819.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.